Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I, 90-Day Safety, Pharmacokinetic, And Pharmacodynamic Study Of Intravaginal Rings Releasing Tenofovir And Levonorgestrel

NCT03279120 is registered in ClinicalTrials.gov with CONRAD as lead sponsor.

NCT NCT03279120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03279120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I, 90-Day Safety, Pharmacokinetic, And Pharmacodynamic Study Of Intravaginal Rings Releasing Tenofovir And Levonorgestrel
Lead sponsor
CONRAD
Phase
Phase 1
Overall status
Completed
Start date
September 28, 2017
Completion date
December 26, 2018
Enrollment
66 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anti-infective agents, anti-retroviral agents, contraceptive usage